TLR2 and cervical carcinoma: We show that the TLR2-L SLP conjugates induce significant activation of HPV16-specific CD8+ and CD4+ T cells and robust expression of IFNγ and/or IL-2 by ex vivo stimulated tumor-draining LN-derived T cells of cervical cancer patients.